We are live on ! Find out more
TXMD icon

TherapeuticsMD
TXMD

42 hedge funds and large institutions have $12.5M invested in TherapeuticsMD in 2023 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

349% more call options, than puts

Call options by funds: $651K | Put options by funds: $145K

33% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 3

14% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 7

7% more capital invested

Capital invested by funds: $11.7M → $12.5M (+$807K)

2% more funds holding

Funds holding: 41 → 42 (+1)

3.35% less ownership

Funds ownership: 32.9% → 29.55% (-3.4%)

Holders
42
Holders Change
+1
Holders Change %
+2.44%
% of All Funds
0.66%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
8
Reduced
7
Closed
3
Calls
$651K
Puts
$145K
Net Calls
+$506K
Net Calls Change
+$285K

Top Buyers

Rank Fund Capital Flow
1
CC
Clearline Capital
New York
+$141K
2
BlackRock
BlackRock
New York
+$82.4K
3
TC
Tejara Capital
United Kingdom
+$54.6K
4
Osaic Holdings
Osaic Holdings
Arizona
+$11.8K
5
Northern Trust
Northern Trust
Illinois
+$3K

Top Sellers

Rank Fund Capital Flow
1
SSP
Sixth Street Partners
Texas
-$467K
2
SFI
Susquehanna Fundamental Investments
Pennsylvania
-$56.8K
3
Group One Trading
Group One Trading
Illinois
-$34.4K
4
SMH
Sanders Morris Harris
Texas
-$33.7K
5
UBS Group
UBS Group
Switzerland
-$12.3K
Name Holding Trade Value Shares
Change 		Change in
Stake
TRCT
26
Tower Research Capital (TRC)
New York
$1.22K +$1.09K +277 +1,539%
US Bancorp
27
US Bancorp
Minnesota
$1.01K – – –
SF
28
Safeguard Financial
Wisconsin
$1K +$59 +15 New
RhumbLine Advisers
29
RhumbLine Advisers
Massachusetts
$576 +$549 +140 New
Citadel Advisors
30
Citadel Advisors
Florida
$499 +$475 +121 New
HNB
31
Huntington National Bank
Ohio
$494 – – –
WP
32
WealthPLAN Partners
Nebraska
$391 – – –
CMA
33
Cedar Mountain Advisors
Oregon
$165 – – –
FWM
34
Focused Wealth Management
New York
$66 – – –
IA
35
IFP Advisors
Florida
$66 – – –
PTC
36
Private Trust Company
Ohio
$66 – – –
PNC Financial Services Group
37
PNC Financial Services Group
Pennsylvania
$49 +$47 +12 New
SPIA
38
Steward Partners Investment Advisory
New York
$45 – – –
HI
39
Harbour Investments
Wisconsin
$33 – – –
GWMI
40
Guardian Wealth Management (Illinois)
Illinois
$8 – – –
APC
41
Aspire Private Capital
North Carolina
$4 – – –
SSP
42
Sixth Street Partners
Texas
– -$467K -124,659 Closed
Group One Trading
43
Group One Trading
Illinois
– -$34.4K -8,770 Closed
Northwestern Mutual Wealth Management
44
Northwestern Mutual Wealth Management
Wisconsin
– -$525 -140 Closed
1
2

TXMD Hedge Fund Activity: Q2 2023 in Review

42 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in TherapeuticsMD (TXMD) for Q2 2023, worth a combined $12.5M — up 6.9% from $11.7M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new TXMD positions and 3 closed out — a net gain of 1 holder — while 8 added to existing stakes and 7 trimmed.

The largest buyer was Clearline Capital, adding an estimated $141K. The largest seller was Sixth Street Partners, exiting entirely with an estimated $467K sold.

  • 42 institutional investors held TherapeuticsMD (TXMD) as of Q2 2023, up from 41 in Q1 2023.
  • Funds reported $12.5M of TherapeuticsMD stock for Q2 2023, up 6.9% quarter-over-quarter.
  • 4 funds opened new TherapeuticsMD positions in Q2 2023 and 3 closed out, a net change of +1 holder.
  • The largest TherapeuticsMD buyer in Q2 2023 was Clearline Capital, an estimated $141K added.
  • The largest TherapeuticsMD seller in Q2 2023 was Sixth Street Partners, an estimated $467K sold.

Based on aggregated 13F filings for Q2 2023.